Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 281.50
-1.00 (-0.35%)
Oct 1, 2026, 5:15 PM GMT
AIM:AMS Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 610 | 470 | 424 | 451 | 561 | 730 | |
Market Cap Growth | 28.71% | 11.01% | -6.07% | -19.69% | -23.12% | 39.54% |
Enterprise Value | 683 | 534 | 379 | 391 | 496 | 680 |
Last Close Price | 2.81 | 2.16 | 1.93 | 2.01 | 2.48 | 3.21 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 170.11 | 47.24 | 59.71 | 28.38 | 27.52 | 41.78 |
Forward PE | 20.57 | 16.87 | 16.08 | 20.13 | 23.31 | 33.87 |
PS Ratio | 2.61 | 2.05 | 2.39 | 3.57 | 4.52 | 6.73 |
PB Ratio | 2.39 | 1.81 | 1.75 | 1.85 | 2.37 | 3.43 |
P/TBV Ratio | 10.80 | 5.68 | 7.95 | 3.50 | 4.21 | 6.29 |
P/FCF Ratio | 49.12 | 18.64 | 27.45 | 51.24 | 24.27 | 24.96 |
P/OCF Ratio | 24.55 | 14.43 | 21.73 | 36.53 | 20.89 | 23.54 |
PEG Ratio | 0.97 | 0.95 | 1.09 | 2.09 | 1.46 | 1.30 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.92 | 2.33 | 2.13 | 3.10 | 3.99 | 6.26 |
EV/EBITDA Ratio | 16.09 | 14.41 | 16.68 | 14.70 | 16.02 | 23.71 |
EV/EBIT Ratio | 28.46 | 23.56 | 33.74 | 20.71 | 19.91 | 29.55 |
EV/FCF Ratio | 54.99 | 21.16 | 24.53 | 44.43 | 21.42 | 23.23 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.33 | 0.31 | 0.36 | 0.04 | 0.04 | 0.05 |
Debt / EBITDA Ratio | 2.01 | 1.99 | 3.40 | 0.32 | 0.30 | 0.33 |
Debt / FCF Ratio | 6.87 | 3.23 | 5.61 | 1.04 | 0.42 | 0.34 |
Net Debt / Equity Ratio | 0.28 | 0.24 | 0.29 | -0.21 | -0.31 | -0.30 |
Net Debt / EBITDA Ratio | 1.87 | 1.71 | 3.06 | -1.92 | -2.34 | -2.20 |
Net Debt / FCF Ratio | 5.78 | 2.52 | 4.51 | -5.80 | -3.13 | -2.16 |
Asset Turnover | 0.59 | 0.59 | 0.52 | 0.44 | 0.47 | 0.45 |
Inventory Turnover | 1.57 | 1.71 | 1.86 | 1.75 | 2.16 | 2.36 |
Quick Ratio | 1.39 | 1.29 | 1.55 | 3.84 | 4.53 | 5.52 |
Current Ratio | 2.94 | 2.79 | 2.85 | 5.67 | 5.82 | 6.76 |
Return on Equity (ROE) | 1.48% | 4.03% | 2.94% | 6.61% | 9.08% | 8.43% |
Return on Assets (ROA) | 3.80% | 3.62% | 2.07% | 4.14% | 5.86% | 5.89% |
Return on Invested Capital (ROIC) | 2.88% | 4.05% | 3.23% | 7.94% | 12.50% | 11.83% |
Return on Capital Employed (ROCE) | 7.00% | 6.60% | 3.30% | 7.10% | 9.60% | 9.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.60% | 2.12% | 1.68% | 3.52% | 3.63% | 2.39% |
FCF Yield | 2.04% | 5.37% | 3.64% | 1.95% | 4.12% | 4.01% |
Dividend Yield | 1.02% | 1.32% | 1.34% | 1.18% | 0.87% | 0.61% |
Payout Ratio | 275.71% | 58.18% | 73.31% | 30.05% | 21.27% | 22.00% |
Buyback Yield / Dilution | -1.18% | -0.78% | 0.45% | 0.09% | -0.53% | -0.22% |
Total Shareholder Return | -0.17% | 0.54% | 1.80% | 1.26% | 0.33% | 0.39% |